Literature DB >> 15094474

Expression of nNOS and soluble guanylate cyclase in schizophrenic brain.

Hajime Baba1, Toshihito Suzuki, Heii Arai, Piers C Emson.   

Abstract

Recent evidence suggests that nitric oxide (NO) systems are affected in the pathophysiology of schizophrenia. We quantified levels of neuronal NO synthase (nNOS) and soluble guanylate cyclase (sGC) subunit mRNAs in the prefrontal cortex of post-mortem brains from individuals with schizophrenia and controls using real-time quantitative PCR, to determine whether levels of nNOS and sGC subunits are altered in 'schizophrenic' brains. Neuronal NOS expression in the prefrontal cortex was significantly higher in individuals with schizophrenia, whereas no significant changes were found in sGC subunit mRNAs in people with schizophrenia or in controls. Abnormalities of nNOS expression in the brain might contribute to the development of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094474     DOI: 10.1097/00001756-200403220-00020

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  15 in total

Review 1.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

Review 2.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

3.  Information processing deficits and nitric oxide signalling in the phencyclidine model of schizophrenia.

Authors:  Erik Pålsson; John Lowry; Daniel Klamer
Journal:  Psychopharmacology (Berl)       Date:  2010-08-28       Impact factor: 4.530

4.  A NOS1 variant implicated in cognitive performance influences evoked neural responses during a high density EEG study of early visual perception.

Authors:  Therese O'Donoghue; Derek W Morris; Ciara Fahey; Andreia Da Costa; John J Foxe; Doreen Hoerold; Daniela Tropea; Michael Gill; Aiden Corvin; Gary Donohoe
Journal:  Hum Brain Mapp       Date:  2011-04-21       Impact factor: 5.038

5.  Evidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controls.

Authors:  Zhifang Zhang; Xiongying Chen; Ping Yu; Qiumei Zhang; Xiaochen Sun; Huang Gu; Hao Zhang; Jinguo Zhai; Min Chen; Boqi Du; Xiaoxiang Deng; Feng Ji; Chuanyue Wang; Yutao Xiang; Dawei Li; Hongjie Wu; Jun Li; Qi Dong; Chuansheng Chen
Journal:  Neuropsychopharmacology       Date:  2014-12-10       Impact factor: 7.853

6.  Meta-analysis of oxidative stress in schizophrenia.

Authors:  Joshua Flatow; Peter Buckley; Brian J Miller
Journal:  Biol Psychiatry       Date:  2013-05-15       Impact factor: 13.382

7.  Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice.

Authors:  Ana C Issy; João Francisco C Pedrazzi; Bruno H Yoneyama; Elaine A Del-Bel
Journal:  Psychopharmacology (Berl)       Date:  2013-10-08       Impact factor: 4.530

Review 8.  Neurobiology of schizophrenia onset.

Authors:  Tsung-Ung W Woo
Journal:  Curr Top Behav Neurosci       Date:  2014

9.  Nitric oxide in the cerebellum of mutant mice.

Authors:  Mario-Ubaldo Manto; Hossein Fatemi
Journal:  Cerebellum       Date:  2004       Impact factor: 3.648

10.  Nitric oxide as inflammatory mediator in post-traumatic stress disorder (PTSD): evidence from an animal model.

Authors:  Frasia Oosthuizen; Gregers Wegener; Brian H Harvey
Journal:  Neuropsychiatr Dis Treat       Date:  2005-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.